Enzon Pharmaceuticals, Inc. (ENZN) Swings to Q1 Loss

Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) reported Q1 EPS of ($0.02), versus $0.01 reported last year. Revenue for the quarter came in at $10.6 million, versus $18.02 million reported last year.

For earnings history and earnings-related data on Enzon Pharmaceuticals, Inc. (ENZN) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c